Matthew J. Osberg - 17 Feb 2026 Form 3 Insider Report for Inspire Medical Systems, Inc. (INSP)

Reporting relationship: Chief Financial Officer
Issuer ticker: INSP
Reported as of: 17 Feb 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 24 Feb 2026, 18:53:47 UTC
Prior SEC filing: 05 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Bryan Phillips, Attorney-in-Fact for Matthew J. Osberg

Key filing fact

Matthew J. Osberg filed Form 3 for Inspire Medical Systems, Inc. (INSP) on 24 Feb 2026.

Key facts

This page summarizes Matthew J. Osberg's Form 3 filing for Inspire Medical Systems, Inc. (INSP).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Feb 2026, 18:53.

Change

Previous filing in this sequence was filed on 05 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001894061 Primary reporting owner

Osberg Matthew J

Relationship: Chief Financial Officer
Address: C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Matthew J. Osberg
Signature date: 24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,794
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on January 31, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney.